Search results
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
Morningstar· 15 hours agoGlobal licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential ...
Nanobiotix reports progress and financial results for 2023 By Investing.com
Investing.com· 14 hours agoThe company highlighted the expansion of its radioenhancer NBTXR3's global potential through a...
Essential Pharma Announces the Acquisition of Reminyl® (galantamine hydrobromide) Oral Capsules
Morningstar· 1 week agoEssential Pharma Announces the Acquisition of Reminyl® (galantamine hydrobromide) Oral Capsules Reminyl® is an established CNS brand for the symptomatic treatment of mild to moderately severe ...